Clinical Trial: A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Study Status: Completed
Recruit Status: RECRUITING
Condition: Growth Hormone Deficiency
Study Type: OBSERVATIONAL
Official Title: A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Brief Summary:
The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under real-world conditions in the post-marketing setting.
Read more